| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69238-1261-9 | 69238-1261 | HUMAN PRESCRIPTION DRUG | Fenofibrate | Fenofibrate | TABLET | ORAL | 20180215 | N/A | ANDA | ANDA209951 | Amneal Pharmaceuticals NY LLC | FENOFIBRATE | 145 mg/1 | 90 TABLET in 1 BOTTLE (69238-1261-9) |
| 69238-1260-9 | 69238-1260 | HUMAN PRESCRIPTION DRUG | Fenofibrate | Fenofibrate | TABLET | ORAL | 20180215 | N/A | ANDA | ANDA209951 | Amneal Pharmaceuticals NY LLC | FENOFIBRATE | 48 mg/1 | 90 TABLET in 1 BOTTLE (69238-1260-9) |
| 73190-016-90 | 73190-016 | HUMAN PRESCRIPTION DRUG | Fenofibrate | Fenofibrate | TABLET | ORAL | 20251201 | N/A | ANDA | ANDA209951 | AvKARE | FENOFIBRATE | 145 mg/1 | 90 TABLET in 1 BOTTLE (73190-016-90) |
| 73190-015-90 | 73190-015 | HUMAN PRESCRIPTION DRUG | Fenofibrate | Fenofibrate | TABLET | ORAL | 20251201 | N/A | ANDA | ANDA209951 | AvKARE | FENOFIBRATE | 48 mg/1 | 90 TABLET in 1 BOTTLE (73190-015-90) |